WeightWatchers’ stock soars after adding compounded GLP-1 treatment to its offering

“With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management solution that is both accessible and affordable,” said Interim Chief Executive Tara Comonte in prepared remarks.

Previous post ‘I want the calls and letters to stop’: My mother died owing $17,000 in credit-card debt. The creditors want their money. Will I have to sell her house?
Next post Qualcomm’s stock isn’t the AI play that it was expected to be, analyst says